BIIB vs AAPL: Which Stock is Better?

Side-by-side comparison of Biogen Inc and Apple Inc in 2026

Comparison Updated:

BIIB

Biogen Inc

$191.82

AAPL

Apple Inc

$264.55

Key Metrics Comparison

MetricBIIBAAPLWinner
Market Cap$28.15BN/ABIIB
P/E Ratio21.8233.85BIIB
EPS (TTM)$8.79$7.55BIIB
Revenue Growth-0.1%6.4%AAPL
Gross Margin78.9%46.9%BIIB

Analyze BIIB

Full quant analysis

Analyze AAPL

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is BIIB or AAPL a better investment?

Comparing BIIB and AAPL: Biogen Inc has a market cap of $28.15B while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between BIIB and AAPL?

BIIB (Biogen Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: BIIB or AAPL?

Based on P/E ratios, BIIB trades at a lower multiple (21.8x vs 33.8x).

Which is growing faster: BIIB or AAPL?

AAPL has higher revenue growth at 6.4% vs -0.1% for BIIB.

Which company is more profitable: BIIB or AAPL?

Biogen Inc (BIIB) has higher gross margins at 78.9% compared to 46.9% for AAPL.

Which is the larger company: BIIB or AAPL?

Biogen Inc (BIIB) is larger with a market cap of $28.15B compared to N/A for AAPL.

Should I buy BIIB or AAPL in 2026?

Both BIIB and AAPL have investment merit. BIIB trades at $191.82 while AAPL trades at $264.55. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between BIIB and AAPL stock?

Key differences: Market Cap ($28.15B vs N/A), P/E Ratio (21.8x vs 33.8x), Revenue Growth (-0.1% vs 6.4%), Gross Margin (78.9% vs 46.9%).

Popular Stock Comparisons